The Global Hereditary Angioedema Market Was Valued At $1,563.7 Million In 2016 And Is Expected To Grow At A 9.1 Percent Cagr During The Forecast Period

 

Pharmaceutical

 

Hereditary angioedema (HAE) is a rare immune-related condition. The potentially fatal condition is caused by a lack of C1-esterase inhibitor (C1-INH), which causes blood vessels to dilate. The disease's symptoms include recurring episodes of edoema in various body parts such as the hands, feet, face, and airways. Based on the reduction in inhibitor synthesis or the formation of a dysfunctional protein, HAE is classified into three types: Type I HAE, Type II HAE, and Type III HAE. Although the condition is hereditary, the absence of a family history does not rule out the diagnosis of HAE, as up to 25% of HAE cases are caused by a spontaneous mutation of the C1-inhibitor gene at conception.

 

The global Hereditary Angioedema Market was valued at $1,563.7 million in 2016 and is expected to grow at a 9.1 percent CAGR during the forecast period (2017 - 2025). The growing number of hereditary angioedema cases, as well as the disease's hereditary nature, which allows the disease to pass the defective gene to future generations, are expected to drive market growth. According to a 2015 survey by the International Hereditary Angioedema Organization (HAEi), the global prevalence of hereditary angioedema is estimated to be 1 in 10,000 to 50,000 people, implying that approximately a quarter million people worldwide suffer from this rare and life-threatening deficiency condition.

 

Because of the greater number of drugs approved in the region, the presence of major manufacturers, and the presence of various organisations serving HAE patients, North America dominates the hereditary angioedema market. CSL Behring, Shire Plc., Pharming Healthcare, Inc., BioCryst Pharmaceuticals, Inc., Ionis Pharmaceuticals, Inc., Arrowhead Pharmaceuticals, Adverum Biotechnologies, and Attune Pharmaceuticals, Inc. are the major players in the global hereditary angioedema market. The FDA approved Haegarda (C1-esterase inhibitor) manufactured by CSL Behring for routine prophylaxis to prevent HAE attacks in adolescent and adult patients in 2017. However, the disease's rarity makes efficient diagnosis difficult, and patients must rely on alternative therapies to control the disease, which is one of the major factors limiting market growth.

Comments

Post a Comment

Popular posts from this blog

Air Purifier works as a Sanitizer in the air which helps in reducing pollutants, allergens, and toxins

Image
  Air purifier   Within a confined area, an air purifier eliminates organic and inorganic impurities from the air. The clean air is sent out into the living space after these devices catch pollutants and particles in the air. Dust mites, mould spores, chemicals, poisons, and scents are all trapped by these filters. These gadgets are frequently touted as appropriate tools for asthmatic patients and others who suffer from airborne allergen allergies. An indoor Air purifier ensures the filtering of the air inside a closed room, which it catches and releases as clean air. If the windows may be opened, it functions in addition to the necessary natural ventilation. A contrast must be noted between a professional model and a residential device, since neither provides the same level of air treatment or overall performance. Pollens, fine particles PM2.5 and PM10, VOCs (Volatile Organic Compounds), viruses, and germs are all effectively removed by a professional air purifier with a HEPA 13 or
Read more

Polyethylene Terephthalate Is A Non-Toxic Plastic, Mostly Used For Manufacturing Medical Devices

Image
  Polyethylene Terephthalate Polyethylene Terephthalate is an extremely common plastic. It is used in water bottles, clothing, baby wipes and many other items. The material is also a major component of many textiles. It can be melted or injected into molds to create a variety of shapes. It can also be used as a thin film that can protect products from light, heat and moisture. The material is a linear thermoplastic composed of repeating units of ethylene glycol and terephthalic acid. It can be spun into fibers for synthetic fabrics, formed into containers for liquids and food, thermoformed into manufacturing parts, or combined with glass fiber to make engineering resins. Polyethylene Terephthalate is the most common plastic of the polyester family and is one of the most widely-used materials in the world. It is a strong, stiff plastic with good electrical insulating properties and excellent mechanical strength, transparency, gas barrier properties and stability over a wide temperat
Read more

With the use of High-Frequency alternating current, Radiofrequency Ablation Device convert Electromagnetic Energy into Heat Energy

Image
Radiofrequency Ablation Device RFA is a minimally invasive technique that may be done in a doctor's office or a hospital. The majority of patients are able to return home the same day. RFA can be done with or without minimal sedation. If anaesthesia is utilised, the patient is generally kept awake and alert enough to explain what they are feeling during the nerve stimulation and lesioning. The following are the steps involved in an RFA: ·         On a procedure table, the patient is lying on his or her stomach. An intravenous (IV) line is established if sedation is utilised so that relaxation medication (sedation) can be administered. ·         To reduce the danger of infection, the skin above the treatment region (neck, mid-back, or low back) is thoroughly washed. ·         A numbing drug (anaesthetic) is injected into the location of the RFA injection site to numb a small patch of skin. Radiofrequency ablation is a process that is reasonably safe and low-risk. Some pati
Read more